BioMed Realty Trust, Inc. (BMR) Reports In-Line Q2 FFO, Revenues Top Slightly
Tweet
Share
E-mailGet Alerts BMR Hot Sheet
Price: $1.31 +2.34%
Financial Fact:
Interest expense: -21.23M
Today's EPS Names:
BTTX, VAXX, ELYS, More
Financial Fact:
Interest expense: -21.23M
Today's EPS Names:
BTTX, VAXX, ELYS, More
Join SI Premium – FREE
BioMed Realty Trust, Inc. (NYSE: BMR) reported Q2 FFO of $0.29, in-line with the analyst estimate of $0.29. Revenue for the quarter came in at $106.8 million versus the consensus estimate of $105.56 million.
BioMed Realty Trust, Inc. sees FY2011 FFO of $1.16-$1.20, versus the consensus of $1.18.
BioMed Realty Trust, Inc. sees FY2011 FFO of $1.16-$1.20, versus the consensus of $1.18.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BJ's Wholesale Club (BJ) Tops Q2 EPS by 19c, Beats on Revenue; Offers FY27 EPS Guidance
- Alibaba stock dips as Q2 profit misses estimates despite strong AI cloud growth
- Analog Devices (ADI) Tops Q3 EPS by 11c, Beats on Revenue; Offers Q4 Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
